139 related articles for article (PubMed ID: 4397668)
1. Pharmacological studies on 8-[(1,4-benzodioxan-2-yl) methyl]-3-oxo-1-thia-4,8-diazaspiro-[4,5]-decane maleate.
Nakanishi M; Imamura H; Sagara S; Yamaguchi N; Nakamura T
Jpn J Pharmacol; 1971 Jun; 21(3):361-75. PubMed ID: 4397668
[No Abstract] [Full Text] [Related]
2. Pharmacological studies of o-chloro-alpha-[(tert.-butylamino)methyl]benzylalcohol hydrochloride (C-78), a new bronchodilator. II. Actions on the cardio-vascular system and smooth muscle organs.
Kubo S; Uesaka I; Matsubara I; Ishihara T; Kasé Y
Arzneimittelforschung; 1977 Jul; 27(7):1433-9. PubMed ID: 20115
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships in the adrenergic-blocking agents.
Ghouri MS; Haley TJ
J Pharm Sci; 1969 May; 58(5):511-38. PubMed ID: 4389589
[No Abstract] [Full Text] [Related]
4. [Pharmacological effects of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propanol (ifenprodil), with special reference to its effects on isolated arteries].
Mizusawa H; Fujiwara H
Nihon Yakurigaku Zasshi; 1974 Nov; 70(6):785-99. PubMed ID: 4156926
[No Abstract] [Full Text] [Related]
5. Competitive blockade of adrenergic alpha-receptors and histamine receptors by thymoxamine.
Birmingham AT; Szolcsányi J
J Pharm Pharmacol; 1965 Jul; 17(7):449-58. PubMed ID: 4379268
[No Abstract] [Full Text] [Related]
6. [Studies on the pharmacodynamics of carbochromen].
Nitz RE
Arzneimittelforschung; 1970 Mar; 20():433-8. PubMed ID: 4318217
[No Abstract] [Full Text] [Related]
7. Autonomic blocking properties of Wy 21901.
Alps BJ; Hill M; Johnson ES; Wilson AB
Br J Pharmacol; 1970 Sep; 40(1):153P. PubMed ID: 4395084
[No Abstract] [Full Text] [Related]
8. Adrenergic receptors on some organs.
Takagi K; Osada E; Takayanagi I; Taga F
Arch Int Pharmacodyn Ther; 1967 Jul; 168(1):212-9. PubMed ID: 4383015
[No Abstract] [Full Text] [Related]
9. Chemico-pharmacological studies on saponins of Panax ginseng C. A. Meyer. II. Pharmacological part.
Kaku T; Miyata T; Uruno T; Sako I; Kinoshita A
Arzneimittelforschung; 1975 Apr; 25(4):539-47. PubMed ID: 239732
[TBL] [Abstract][Full Text] [Related]
10. Nonequilibrium alpha adrenergic blockade and neuroleptic activity of N-ethoxycarbonyl-1,dihydroquinoline (BC-347).
Martel RR
J Pharmacol Exp Ther; 1969 Mar; 166(1):44-51. PubMed ID: 4304784
[No Abstract] [Full Text] [Related]
11. Dopamine-induced relaxation of isolated arterial strips.
Toda N; Goldberg LI
J Pharm Pharmacol; 1973 Jul; 25(7):587-9. PubMed ID: 4147064
[No Abstract] [Full Text] [Related]
12. [Pharmacological properties of methylscopolammonium methylsulfate].
Kasahara A; Kojima H; Onodera T; Hashizume T; Yamasaki T
Nihon Yakurigaku Zasshi; 1971 Jan; 67(1):100-24. PubMed ID: 4396034
[No Abstract] [Full Text] [Related]
13. Dimethyl isopropylmethoxamine: a selective beta-receptor blocking agent.
Levy B
Br J Pharmacol Chemother; 1966 Aug; 27(2):277-85. PubMed ID: 5967366
[No Abstract] [Full Text] [Related]
14. Studies on capsella bursa pastoris. I. General pharmacology of ethanol extract of the herb.
Kuroda K; Takagi K
Arch Int Pharmacodyn Ther; 1969 Apr; 178(2):382-91. PubMed ID: 5389956
[No Abstract] [Full Text] [Related]
15. RA 642, a pyrimido-pyrimidine-derivative with vasodilating and hypertensive potency.
Kadatz R; Kobinger W; Walland A
Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):97-103. PubMed ID: 940597
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological studies of 3-[bis(3,3-diphenylpropyl)-amino]-propan-1-ol hydrochloride, (PF-244), a new cerebral vasodilator.
Kadokawa T; Fujitani B; Kuwashima J; Hatano N; Shimizu M
Arzneimittelforschung; 1975 Apr; 25(4):632-8. PubMed ID: 1174078
[TBL] [Abstract][Full Text] [Related]
17. The adrenergic blocking activity of N-tert.-butylmethoxamine (butoxamine).
Levy B
J Pharmacol Exp Ther; 1966 Mar; 151(3):413-22. PubMed ID: 4380047
[No Abstract] [Full Text] [Related]
18. Selective blockade of adrenoceptive beta receptors in the heart.
Dunlop D; Shanks RG
Br J Pharmacol Chemother; 1968 Jan; 32(1):201-18. PubMed ID: 4384337
[No Abstract] [Full Text] [Related]
19. Chlorpromazine metabolism. VI. Adrenolytic and antiserotonergic activities of chlorpromazine and its various metabolites.
Kaul PN; Pabrai PR; Farmer M
Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):325-37. PubMed ID: 4149789
[No Abstract] [Full Text] [Related]
20. Effects of a cardio-selective beta-adrenergic blocking agent on the heart and coronary circulation.
Ross G; Jorgensen CR
Cardiovasc Res; 1970 Apr; 4(2):148-53. PubMed ID: 4392942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
